APL Bioengineering

Papers
(The H4-Index of APL Bioengineering is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)
ArticleCitations
The rheology of direct and suspended extrusion bioprinting147
Emergence of FRESH 3D printing as a platform for advanced tissue biofabrication132
Artificial intelligence for brain diseases: A systematic review95
Recent advances on polymeric hydrogels as wound dressings92
Functional hydrogels for diabetic wound management68
Skin-on-a-chip models: General overview and future perspectives58
Microglia-targeting nanotherapeutics for neurodegenerative diseases55
Complex 3D bioprinting methods54
Sex differences in the blood–brain barrier and neurodegenerative diseases52
Evaluation of current diagnostic methods for COVID-1951
Wearable devices for continuous monitoring of biosignals: Challenges and opportunities51
Recent advancements in enzyme-mediated crosslinkable hydrogels: In vivo-mimicking strategies46
The effects of surface topography modification on hydrogel properties40
Nuclear lamins: Structure and function in mechanobiology38
Mind the gap: State-of-the-art technologies and applications for EEG-based brain–computer interfaces36
Fundamentals of light-cell–polymer interactions in photo-cross-linking based bioprinting34
Cyclic tangential flow filtration system for isolation of extracellular vesicles33
Toward improved in vitro models of human cancer33
Brain-on-a-Chip: Characterizing the next generation of advanced in vitro platforms for modeling the central nervous system29
New contrast agents for photoacoustic imaging and theranostics: Recent 5-year overview on phthalocyanine/naphthalocyanine-based nanoparticles29
Peptide functionalized liposomes for receptor targeted cancer therapy28
Atomic force microscopy—A tool for structural and translational DNA research27
Biomaterials-based formulations and surfaces to combat viral infectious diseases27
Reconstituting the dynamics of endothelial cells and fibroblasts in wound closure26
Liver–Heart on chip models for drug safety26
0.14760279655457